Directors report The Directors are pleased to present their Report and the Dividend audited accounts for the year ended 31st December 2011.
An interim cash dividend of 14.8p per share 2010: 13.0p was paid to shareholders in November 2011.
The Directors Principal activities are now recommending the payment of a final dividend of Spirax Sarco is a UK-based multi-national engineering 34.2p per share 2010: 30.0p which, if approved at the Group, tightly focused on its two niche businesses of steam Annual General Meeting, will be paid on 18th May 2012 system specialties and peristaltic pumps.
to shareholders on the Register of Members on 20th April At the heart of the Groups robust and resilient business 2012.
The total distribution for the year will thus be 49.0p model is our worldwide direct selling approach.
directly with customers, our sales engineers apply our Special dividend application and systems knowledge, breadth of products The Directors also recommended the payment of a special and services, experience and global presence to enable final dividend of 25.0p per share in respect of 2010 which the Group to offer the most extensive range of engineered was approved at the Annual General Meeting in May 2011 solutions that generate cost savings and process and was paid on 8th July 2011 to shareholders on the improvements.
The business benefits from the great diversity Register of Members on 10th June 2011. of our end user industries and customers, geographic spread and significant exposure to emerging markets, the Corporate governance high level of replacement content in our revenue stream and The Boards assessment of corporate governance is set a large base of industrial steam systems installed around the out on pages 36 to 42 and all information contained in that world that need continual upkeep and improvement.
assessment is to be treated as having been incorporated into this Report.
The Spirax Sarco steam business is the global leader in the supply of engineered solutions for the design, maintenance Directors and operation of efficient industrial and commercial steam Biographical details of the Directors who served throughout systems.
As a heat source, steam is the natural choice in the year are set out on pages 32 and 33.
In addition most industrial processes due to its high heat-carrying Mr A J Scrivin was an Executive Director until 31st July 2011 capacity, controllability, sterility and efficiency as a heat when he retired and Mr M E Gibbin was an Executive transfer fluid.
Spirax Sarcos engineered solutions are Director until 19th October 2011 when he resigned from the Board.
used in a wide variety of process industries including foods, beverages and brewing, pharmaceuticals, oil In accordance with the UK Corporate Governance Code and petrochemicals, fine chemicals, mining and metals all the Directors will retire and, being eligible, will offer processing, plastics and textiles.
The Group also provides themselves for re-election at the Annual General Meeting.
a wide range of products, engineered packages and services Mr M E Vernon, Mr N H Daws and Mr D J Meredith each for space heating, humidification, sterilisation, steam and have a service contract which is determinable on 12 months' hot water generation for hospitals, public buildings, notice.
Mr W H Whiteley, as Chairman, and Mr G Bullock, academic institutions and commercial buildings.
Dr K Rajagopal and Mr C G Watson, as independent The Watson-Marlow business is the worlds leading Non-Executive Directors, each have a letter of appointment.
specialist and largest manufacturer of peristaltic pumps, The Directors interests in the shares of the Company at the fastest-growing pump type, and other niche pumps.
7th March 2012 are set out in the Directors Remuneration Peristaltic pumps are ideal for difficult pumping applications Report on pages 43 to 51. for hygienic, abrasive or corrosive fluids that must be pumped safely, accurately and without contamination in Employment policies applications ranging from high purity biopharmaceuticals Details of the Groups employment policies are set out to wastewater treatment to precious metals processing.
The appointment and replacement of Directors is governed by the Companys Articles of A more detailed description of the Groups activities is set Association, the UK Corporate Governance Code, the out on pages 8 to 21.
Companies Act 2006 and related legislation.
Business Review and Financial Review Annual General Meeting On pages 16 to 27 you will find a review of the development The Annual General Meeting of the Company is to be held and performance of the Group during the year including on Tuesday 15th May 2012 at Charlton House, Cheltenham details of its financial performance, key performance and the Notice of Meeting and an explanation of the indicators and a description of the principal risks and resolutions to be put to the Meeting are set out in the uncertainties facing the business.
Results Share capital The Groups results for the year have been prepared in As at 30th March 2011 there were no treasury shares held accordance with the International Financial Reporting by the Company.
Details of shares issued during the year Standards as adopted by the European Union.
They are are set out in note 24 on page 75. explained in the Chairmans Statement on page 3 and the Business Review and Financial Review on pages 16 to 27 As at 31st December 2011 the Companys share capital was and are also set out in the Group Income Statement which made up of Ordinary shares which each carry one vote at is to be found on page 55.
General Meetings of the Company.
Except as set out in the Articles of Association or in applicable legislation there are no restrictions on the transfer of shares in the Company and there are no restrictions on the voting rights in the Companys shares.
34 Spirax-Sarco Engineering plc Annual Report and Accounts 2011 The Company is not aware of any agreements entered into Statement of the policy and practice on the between any shareholders in the Company which restrict payment of suppliers the transfer of shares or the exercise of any voting rights It is the Groups policy to meet the terms of all individual attached to the shares.
supply contracts and, in view of this, the Group does not follow any particular prescribed code on the payment The Company is not a party to any significant agreements of suppliers.
that take effect, alter or terminate upon a change of control of the Company following a takeover bid.
The Company had no trade creditors as at 31st December 2011 and consequently creditor days have not been The Companys Articles of Association may be amended by presented in the Report.
special resolution at a General Meeting of the shareholders.
Research and development Powers of the Directors and purchase of own shares The Group continues to devote significant resources Subject to the provisions of the Companys Articles of to the updating and expansion of its range of products and Association, the Directors may exercise all the powers engineered packages in order to remain at the forefront of the Company.
No purchases of shares were made of its world markets.
Expenditure in 2011 on research and by the Company during the year and therefore, as at development R&D amounted to 11,453,000 2010: 31st December 2011, the number of shares which may 8,909,000, of which 2,727,000 2010: 1,795,000 is be purchased in accordance with the authority given by capitalised, as explained in note 1 on page 60.
During the shareholders at the 2011 Annual General Meeting was year the Group has continued to increase its R&D capability 7,718,059 and the total number of shares in issue was in the separate R&D function based in Cheltenham.
This 77,674,152. function is tasked with improving the Groups pipeline of Major shareholdings new products, decreasing the time to launch, expanding the As at 31st December 2011 the Company had received Groups addressable market and realising additional sales.
notice of material interests in 3% or more of the issued Fixed assets share capital of the Company as follows: In the opinion of the Directors, the market value of the land As at 31.12.11 and buildings of the Group exceeds the book value of those % of assets at 31st December 2011 by approximately issued Number of 12,000,000 2010: 12,000,000. share Ordinary Donations capital shares During the year, the Spirax-Sarco Group Charitable Trust BlackRock Investment made charitable donations amounting to 132,400 divided Management UK Ltd 12,370,013 15.93 amongst 58 organisations 2010: 111,500.
Schroder Investment Management Ltd 5,312,710 6.84 There were no political donations made in the year or the prior year.
Sprucegrove Investment Management Ltd 3,777,499 4.86 Disclosure of information to auditor As at the date of this Annual Report, as far as each Director Baillie Gifford & Co 3,555,900 4.58 is aware, there is no relevant audit information of which the Legal & General Companys auditor is unaware.
Each Director has taken all Investment Management 2,388,538 3.07 such steps as he ought to have taken as a Director in order Between 31st December 2011 and 29th February 2012, the to make himself aware of any relevant audit information and Company had received notice of material interests in 3% or to establish that the Companys auditor is aware of that more of the issued share capital of the Company as follows: information.
For these purposes, relevant audit information means information needed by the Companys auditor in % of connection with preparing their report set out on page 53. issued Number of share As at Ordinary Auditor capital date shares A resolution to reappoint KPMG Audit Plc as the Companys BlackRock Investment auditor will be proposed at the Annual General Meeting.
Management UK Ltd 20.02.12 12,487,706 16.07 Going concern Schroder Investment The Company continues to adopt the going concern basis Management Ltd 29.02.12 5,254,074 6.76 in preparing the Annual Report and Accounts.
More detail Sprucegrove Investment is set out on page 42.
Management Ltd 31.12.11 3,777,499 4.86 By order of the Board Baillie Gifford & Co 29.02.12 3,251,151 4.18 W G Stebbings Legal & General Company Secretary and Solicitor Investment Management 29.02.12 2,409,389 3.10 7th March 2012 Financial instrument risk Spirax-Sarco Engineering plc The main risks arising from the Groups financial instruments Registered no.
596337 are interest rate risk, liquidity risk and foreign currency risk.
More detail is set out in note 32 on pages 88 to 93.
Spirax-Sarco Engineering plc Annual Report and Accounts 2011 35
